# EDGAR Filing Document

**Accession Number:** 0001820190
**File Stem:** 0001193125-23-023106
**Filing Date:** 2023-2
**Character Count:** 62605
**Document Hash:** cd227cdfe5ed54d34200845a8ce14b9f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-023106.hdr.sgml**: 20230203

**ACCESSION NUMBER**: 0001193125-23-023106

**CONFORMED SUBMISSION TYPE**: 424B3

**PUBLIC DOCUMENT COUNT**: 4

**FILED AS OF DATE**: 20230203

**DATE AS OF CHANGE**: 20230202

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Scilex Holding Co
- **CENTRAL INDEX KEY:** 0001820190
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 424B3
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-269205
- **FILM NUMBER:** 23583470

**BUSINESS ADDRESS:**
- **STREET 1:** 960 SAN ANTONIO ROAD
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94303
- **BUSINESS PHONE:** (650) 516-4310

**MAIL ADDRESS:**
- **STREET 1:** 960 SAN ANTONIO ROAD
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94303

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Scilex Holding Company/DE
- **DATE OF NAME CHANGE:** 20221117

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Vickers Vantage Corp. I
- **DATE OF NAME CHANGE:** 20200804

**Filed pursuant to Rule 424(b)(3)** 

**Registration No. 333-269205** 

**PROSPECTUS SUPPLEMENT NO. 2** 

**(to Prospectus dated January 20, 2023)** 

## Scilex Holding Company
**Up to 28,128,422 Shares of Common Stock** 

------

This prospectus supplement supplements the prospectus dated January 20, 2023 (the "Prospectus"), which forms a part of our registration statement on Form S-1 (No. 333-269205). This prospectus supplement is being filed to update and supplement the information in the Prospectus with the information contained in our Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 2, 2023 (the "Current Report"). Accordingly, we have attached the Current Report to this prospectus supplement.

The Prospectus and this prospectus supplement relate to the resale from time to time of up to 28,128,422 shares of our common stock, par value $0.0001 per share (the "Common Stock"), by B. Riley Principal Capital II, LLC, a Delaware limited liability company (the "Selling Securityholder"). The shares included in the Prospectus and this prospectus supplement consist of shares of Common Stock that we have issued or that we may, in our discretion, elect to issue and sell to the Selling Securityholder, from time to time, pursuant to a standby equity purchase agreement we entered into with the Selling Securityholder on January 8, 2023 (the "B. Riley Purchase Agreement"), in which the Selling Securityholder has committed to purchase from us, at our direction, up to $500,000,000 of our Common Stock, subject to terms and conditions specified in the B. Riley Purchase Agreement.

Our Common Stock is listed on the Nasdaq Capital Market under the symbol "SCLX". On February 1, 2023, the last reported sales price per share of our Common Stock was $7.00.

This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.

------

**See the section entitled "Risk Factors" beginning on page 13 of the Prospectus as well as risks and uncertainties described under similar headings in any amendments or supplements to the Prospectus to read about factors you should consider before buying our securities.** 

**Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus supplement or the Prospectus. Any representation to the contrary is a criminal offense.** 

------

**The date of this prospectus supplement is February 2, 2023** 

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**FORM 8-K** 

------

**CURRENT REPORT** 

**PURSUANT TO SECTION 13 OR 15(d)** 

**OF THE SECURITIES EXCHANGE ACT OF 1934** 

**Date of Report (Date of earliest event reported): February 2, 2023** 

------

## SCILEX HOLDING COMPANY
**(Exact name of registrant as specified in its charter)** 

------

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-39852** | **92-1062542** |
| **(State or other jurisdiction<br>of incorporation)** | **(Commission<br>File Number)** | **(IRS Employer<br>Identification No.)** |

---

**960 San Antonio Road, Palo Alto, California, 94303** 

**(Address of principal executive offices, including zip code)** 

**Registrant's telephone number, including area code: (650) 516-4310** 

**N/A** 

**(Former name or former address, if changed since last report)** 

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Securities registered pursuant to Section 12(b) of the Act

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading<br>Symbol(s)** | **Name of each exchange**<br> **on which registered** |
| Common stock, par value $0.0001 per share | SCLX | The Nasdaq Stock Market LLC |
| Warrants to purchase one share of common stock, each at an exercise price of $11.50 per share | SCLXW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 7.01.** | **Regulation FD Disclosure.**  |

---

On February 2, 2023, Scilex Holding Company (the "Company"), a subsidiary of Sorrento Therapeutics, Inc. ("Sorrento"), posted under the "Investors" section of its website at www.scilexholding.com a supplemental document containing additional information and responses (the "FAQ Supplement Disclosure") to the frequently asked questions document that was posted by the Company on January 29, 2023 regarding Sorrento's previously disclosed stock dividend consisting of an aggregate of 76,000,000 shares of common stock, par value $0.0001 per share, of the Company held by Sorrento. A copy of the FAQ Supplement Disclosure is (i) furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference and (ii) also posted under the "Investors" section of Sorrento's website at www.sorrentotherapeutics.com. On February 2, 2023, the Company issued a press release regarding the FAQ Supplement Disclosure. A copy of the press release is furnished herewith as Exhibit 99.2 to this Current Report on Form 8-K.

The information under this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2 hereto, is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Securities Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing. This report will not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.

---

| | |
|:---|:---|
| **Item 9.01.** | **Financial Statements and Exhibits.**  |

---

(d) Exhibit.

---

| | |
|:---|:---|
| 99.1 | FAQ Supplement Disclosure, dated February 2, 2023. |
| 99.2 | Press Release, dated February 2, 2023. |
| 104 | Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL). |

---

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **SCILEX HOLDING COMPANY** | **SCILEX HOLDING COMPANY** |
| By: | /s/ Jaisim Shah |
| Name: | Jaisim Shah |
| Title: | Chief Executive Officer & President |

---

Date: February 2, 2023

------

---

| | |
|:---|:---|
| ![LOGO](g452367sp04.jpg) <br>sorrentotherapeutics.com<br>4955 Directors Place<br> San Diego, CA 92121 | <br> **Exhibit 99.1**<br>![LOGO](g452367snapb3.jpg)  |

---

*Note to Stockholders of Scilex Holding Company (<u>Scilex</u>): In connection with the dividend by Scilex's controlling stockholder, Sorrento Therapeutics, Inc. (<u>Sorrento</u>), of shares of Scilex common stock held by Sorrento, Sorrento has issued the below "Supplement to Frequently Asked Questions" regarding such dividend. This information is also available on Sorrento's website at <u>www.sorrentotherapeutics.com</u>.* 

------

**SUPPLEMENT TO** 

**FREQUENTLY ASKED QUESTIONS** 

**REGARDING THE DIVIDEND OF SCILEX HOLDING COMPANY COMMON STOCK BY SORRENTO THERAPEUTICS, INC.** 

This supplement is a supplement to the Frequently Asked Questions Regarding the Dividend of Scilex Holding Company Common Stock by Sorrento Therapeutics, Inc. (<u>Sorrento</u>) that was issued by Sorrento on January 29, 2023 (the <u>FAQ</u>), a copy of which can be found under the "Investors" section of its website at <u>www.sorrentotherapeutics.com</u><u>.</u> 

This supplement is being issued to update and supplement the information in the FAQ to notify investors regarding certain matters relating to the dividend and reiterate certain questions and answers from the FAQ. Capitalized terms used in this supplement shall have their respective meetings set forth in the FAQ.

------

**NOTICE OF REMOVAL OF CONTRA-CUSIP BY DTCC** 

**Effective as of February 2, 2023, the Depository Trust and Clearing Corporation (<u>DTCC</u>) has removed the "contra-CUSIP" that it had previously imposed on the Dividend Stock. Any shares of Dividend Stock held by your brokerage firm, bank, dealer or other similar organization for your benefit now bear only Scilex's CUSIP number, which is 80880W106. If you are entitled to receive Dividend Stock, please contact your brokerage firm, bank, or other similar organization immediately to confirm that the CUSIP number appears on your brokerage statement with respect to your Dividend Stock.** 

------

**NOTICE TO BROKERAGE FIRMS, BANKS, DEALERS AND OTHER SIMILAR ORGANIZATIONS** 

**If the name of your firm, bank or other similar organization is set forth on Annex B of the FAQ, which Annex B is repeated below for convenience, and your firm, bank or similar organization has not received the Dividend Confirmation that was mailed to your firm, bank or similar organization, please contact Scilex's transfer agent immediately to obtain a copy of the Dividend Confirmation. Scilex's transfer agent's contact information is as follows:** 

**Continental Stock Transfer & Trust Company** 

**Telephone Number**: 800-509-5586

**Email Address**: cstmail@continentalstock.com

**Several major brokers have confirmed to Sorrento and Scilex that they are adding the Scilex share positions to the individual brokerage accounts of Sorrento shareholders receiving the Dividend Stock.** 

------

---

| | |
|:---|:---|
| ![LOGO](g452367sp04.jpg) <br>sorrentotherapeutics.com<br>4955 Directors Place<br> San Diego, CA 92121 | ![LOGO](g452367snapb3.jpg) |

---

**SUPPLEMENTAL QUESTION AND ANSWER** 

---

| | |
|:---|:---|
| **Q:** | **If I loaned my shares of Sorrento common stock to short sellers or any other party as of the Record Date, am I still entitled to receive Dividend Stock as of the Payment Date?**  |

---

---

| | |
|:---|:---|
| A: | Only Record Holders as of the Record Date are entitled to receive the Dividend Stock. If you were the Record Holder as of the Record Date and are entitled to receive the Dividend Stock, but have not received the Dividend Stock, you may be entitled to receive Dividend Stock from the short seller or other party who borrowed your shares of Sorrento common stock, whether through the lending programs implemented by your brokerage firm, bank, dealer and other similar organization or otherwise. **If you were a Record Holder as of the Record Date and have not received your Dividend Stock, please consult with your financial advisor, broker or other agent immediately to determine how to receive your Dividend Stock.**  |

---

------

---

| | |
|:---|:---|
| ![LOGO](g452367sp04.jpg) <br>sorrentotherapeutics.com<br>4955 Directors Place<br> San Diego, CA 92121 | ![LOGO](g452367snapb3.jpg) |

---

**Annex B** 

**Broker List** 

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| ABN AMRO CLEARING CHICAGO LLC | 175 WEST JACKSON BLVD. <br>CHICAGO <br>IL ILLINOIS <br>60604 US | Albert Fried & Company LLC | 45 BROADWAY, 24TH FLOOR 24TH FLOOR <br>NEW YORK <br>NY NEW YORK <br>10006 US |
| AMALGAMATED BANK | 275 7TH AVENUE <br>NEW YORK <br>NY NEW YORK <br>10003 US | AMERICAN ENTERPRISE INVESTMENT SERVICES INC. | 682 AMERIPRISE FINANCIAL CENTER <br>MINNEAPOLIS <br>MN MINNESOTA <br>55474 US |
| APEX CLEARING CORPORATION | 2 GATEWAY CENTER 283-299 MARKET ST <br>16TH FLOOR <br>NEWARK <br>NJ NEW JERSEY <br>07102-5005 US | BANK OF AMERICA, NA/GWIM TRUST OPERATIONS | 901 MAIN STREET <br>12TH FLOOR <br>DALLAS <br>TX TEXAS <br>23113 US |
| BANK OF NEW YORK MELLON | 111 SANDERS CREEK PARKWAY 2ND FLOOR <br>2ND FLOOR <br>EAST SYRACUSE | BARCLAYS CAPITAL INC. | DTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS-MILLER OR ROBERT |

---

------

---

| | |
|:---|:---|
| ![LOGO](g452367sp04.jpg) <br>sorrentotherapeutics.com<br>4955 Directors Place<br> San Diego, CA 92121 | ![LOGO](g452367snapb3.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
|  | NY NEW YORK <br>13057 US. |  | MENDEZ <br>JERSEY CITY <br>NJ NEW JERSEY <br>07310 US |
| BARCLAYS CAPITAL INC. | DTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS-MILLER OR ROBERT MENDEZ <br>JERSEY CITY <br>NJ NEW JERSEY <br>07310 US | BMO CAPITAL MARKETS CORP. | 3 2ND STREET <br>12TH FLOOR <br>JERSEY CITY <br>NJ NEW JERSEY <br>07302 US |
| BMO HARRIS BANK NA/TRUST | 11270 W PARK PL <br>MILWAUKEE <br>WI WISCONSIN <br>53224 US | BMO Nesbitt Burns Inc., Toronto | 250 YONGE STREET, 7TH FLOOR <br>7TH FLOOR <br>TORONTO <br>ON ONTARIO <br>M5B 2M8 CA CANADA |
| BNP PARIBAS, NEW YORK BRANCH/BNP PARIBAS PRIME BROKERAGE CUSTODIAN | 100 WEST 33RD STREET <br>3RD FLOOR <br>NEW YORK <br>NY NEW YORK <br>10001 | BNP PARIBAS, NEW YORK BRANCH/BNP PARIBAS PRIME BROKERAGE CUSTODIAN | 100 WEST 33RD STREET <br>3RD FLOOR <br>NEW YORK <br>NY NEW YORK <br>10001 |
| BNY MELLON | PO BOX 392002 <br>500 ROSS STREET <br>PITTSBURGH <br>PA PENNSYLVANIA <br>15262 US | BNY MELLON/WEALTH MANAGEMENT | 1 FREEDOM VALLEY DRIVE <br>OAKS <br>PA PENNSYLVANIA <br>19456 US |
| BNYMELLON | 111 SANDERS CREEK PARKWAY 2ND FLOOR <br>2ND FLOOR <br>EAST SYRACUSE <br>NY NEW YORK <br>13057 US | BNYMELLON/RE BARCLAYS CAPITAL SECURITIES LTD. | ONE WALL STREET <br>NEW YORK <br>NY NEW YORK <br>10286 |

---

------

---

| | |
|:---|:---|
| ![LOGO](g452367sp04.jpg) <br>sorrentotherapeutics.com<br>4955 Directors Place<br> San Diego, CA 92121 | ![LOGO](g452367snapb3.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| BNYMELLON/RE CACEIS BANK LUXEMBOURG | 500 Grant St. <br>BNY Mellon Center <br>PITTSBURGH <br>PA PENNSYLVANIA <br>15258 | BNYMELLON/RE CACEIS BANK, NETHERLANDS | 111 SANDERS CREEK PARKWAY <br>EAST SYRACUSE <br>NY NEW YORK <br>13057 |
| BNYMELLON/RE CHARLES STANLEY AND COMPANY, LIMITED | 111 SANDERS CREEK PARKWAY 2ND FLOOR <br>2ND FLOOR <br>EAST SYRACUSE <br>NY NEW YORK <br>13057 US | BNYMELLON/RE ETF - ISHARES DTC/NSCC | 111 SANDERS CREEK PARKWAY <br>EAST SYRACUSE <br>NY NEW YORK <br>13057 |
| BNYMELLON/RE WINTERFLOOD SECURITIES LTD | 500 Grant St. <br>BNY Mellon Center <br>PITTSBURGH <br>PA PENNSYLVANIA <br>15258 | BOFA | 4804 Deer Lake Drive East <br>FL9-803-04-04- 4th floor <br>JACKSONVILLE <br>FL FLORIDA <br>32246 US |
| BOFA | 4804 Deer Lake Drive East <br>FL9-803-04-04- 4th floor <br>JACKSONVILLE <br>FL FLORIDA <br>32246 US | BOFA SECURITIES INC | 4804 Deer Lake Drive East <br>FL9-803-04-04- 4th floor <br>JACKSONVILLE <br>FL FLORIDA <br>32246 US |
| BROWN BROTHERS HARRIMAN & CO. | 140 BROADWAY <br>ATTN: CORPORATE ACTIONS VAULT <br>NEW YORK <br>NY NEW YORK <br>10005 US | BROWN BROTHERS HARRIMAN & CO./ETF | 140 BROADWAY <br>NEW YORK <br>NY NEW YORK <br>10005 |
| CALDWELL SECURITIES LTD./CDS\*\* | 55 UNIVERSITY AVENUE <br>SUITE 340 <br>TORONTO <br>ON ONTARIO <br>M5J 2H7 CANADA | CANACCORD GENUITY CORP. | 609 GRANVILLE ST <br>VANCOUVER <br>BC BRITISH COLUMBIA <br>V7Y 1H2 CA CANADA |

---

------

---

| | |
|:---|:---|
| ![LOGO](g452367sp04.jpg) <br>sorrentotherapeutics.com<br>4955 Directors Place<br> San Diego, CA 92121 | ![LOGO](g452367snapb3.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| CANTOR, FITZGERALD & CO. | 135 E 57TH ST 5TH FL <br>NEW YORK <br>NY NEW YORK <br>10041 US | CDS CLEARING AND DEPOSITORY SERVICES INC. | 100 ADELAIDE STREET WEST <br>TORONTO <br>ON ONTARIO <br>M5H 1S3 CA CANADA |
| CETERA INVESTMENT SERVICES LLC | 400 FIRST STREET SOUTH, SUITE 300 <br>SUITE 300 <br>ST. CLOUD <br>MN MINNESOTA <br>56302-0283 US | CHARLES SCHWAB & CO., INC. | 211 MAIN STREET <br>SAN FRANCISCO <br>CA CALIFORNIA <br>94105 US |
| CI INVESTMENT SERVICES INC. | 199 BAY STREET <br>SUITE 2600 <br>TORONTO <br>ON ONTARIO <br>M5L 1E2 CA CANADA | CIBC WORLD MARKETS INC./CDS\*\* | 161 BAY STREET 10 FL <br>TORONTO <br>ON ONTARIO <br>M5J 2S8 CA CANADA |
| CITIBANK, N.A./ETF | 3800 CITIGROUP CENTER <br>B2/2 <br>TAMPA <br>FL FLORIDA <br>33610 | CITIBANK, NATIONAL ASSOCIATION | 3800 CITIBANK CENTER TAMPA <br>BLDG.B FIRST FLOOR ZONE 8 <br>TAMPA <br>FL FLORIDA <br>33610-9122 US |
| CITIGROUP GLOBAL MARKETS, INC. | 580 CROSSPOINT PARKWAY <br>GETZVILLE <br>NY NEW YORK <br>14068 US | CLEAR STREET LLC | 4 World Trade Center, 45th Floor <br>150 Greenwich Street <br>NEW YORK <br>NY NEW YORK <br>10007 |
| CLEARSTREET IO | 55 BROADWAY (SUITE 2102) <br>CORPORATE ACTIONS <br>NEW YORK <br>NEW YORK <br>10006 US | COMMERCE BANK | 922 WALNUT STREET <br>MAIL STOP TBTS-2 <br>KANSAS CITY <br>MO MISSOURI <br>64106 US |
| COR CLEARING LLC | 9300 UNDERWOOD AVE <br>SUITE 400 | Credential Securities Inc. | 800-1111 WEST GEORGIA STREET <br>VANCOUVER |

---

------

---

| | |
|:---|:---|
| ![LOGO](g452367sp04.jpg) <br>sorrentotherapeutics.com<br>4955 Directors Place<br> San Diego, CA 92121 | ![LOGO](g452367snapb3.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
|  | OMAHA <br>NE NEBRASKA <br>68114 US |  | BC BRITISH COLUMBIA <br>V6E 4T6 CA CANADA |
| CREST INTERNATIONAL NOMINEES LIMITED | 33 CANNON STREET <br>LONDON <br>EC4M 5SB GB UNITED KINGDO | CURVATURE SECURITIES, LLC | 39 MAIN STREET <br>CHATHAM <br>NJ NEW JERSEY <br>07928 US |
| D.A. DAVIDSON & CO. | 8 3RD STREET NORTH <br>GREAT FALLS <br>MT MONTANA <br>59401 US | DEPOSITO CENTRAL DE VALORES S.A., DEPOSITO DE VALORES | AVENIDA APOQUINDO # 4001 <br>FLOOR 12, C.P. <br>7550162, SANTIAGO <br>CL CHILE |
| DESJARDINS SECURITIES INC. | 1253 McGill College <br>10TH FLOOR <br>MONTREAL <br>QUEBEC <br>H3B 2Y5 CA CANADA | DEUTSCHE BANK AG NY/US CUSTODY | 1251 Avenue Of The Americas <br>NEW YORK <br>NY NEW YORK <br>10020 |
| DEUTSCHE BANK SECURITIES INC. | 60 WALL STREET <br>9TH FLOOR <br>NEW YORK <br>NY NEW YORK <br>10005 US | DRIVEWEALTH, LLC | 15 EXCHANGE PLACE <br>10TH FLOOR <br>JERSEY CITY <br>NEW JERSEY <br>07302 |
| E\*TRADE CLEARING LLC | HARBORSIDE FINANCIAL CENTER <br>501 PLAZA 11 <br>JERSEY CITY <br>NJ NEW JERSEY <br>07311 US | EDWARD D. JONES & CO., L.P. | 12555 MANCHESTER ROAD <br>ST. LOUIS <br>MO MISSOURI <br>63131-3729 US |
| EDWARD D. JONES & CO., L.P. | 201 PROGRESS PARKWAY <br>MARYLAND HEIGHTS <br>MO MISSOURI <br>63043 US | FIDELITY CLEARING CANADA ULC/CDS\*\* | 483 BAY ST. <br>SOUTH TOWER <br>TORONTO <br>ON ONTARIO <br>M5G2N7 CA CANADA |

---

------

---

| | |
|:---|:---|
| ![LOGO](g452367sp04.jpg) <br>sorrentotherapeutics.com<br>4955 Directors Place<br> San Diego, CA 92121 | ![LOGO](g452367snapb3.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| FIFTH THIRD BANK | 5001 KINGSLEY DRIVE <br>MAIL DROP 1MOB28 <br>CINCINNATI <br>OH OHIO <br>45227 US | FOLIO INVESTMENTS, INC. | 8180 GREENSBORO DRIVE <br>8TH FLOOR <br>MCLEAN <br>VA VIRGINIA <br>22102 US |
| FUTU CLEARING INC. | 12750 Merit Drive <br>SUITE 475 <br>DALLAS <br>TX TEXAS <br>75251 | GMP SECURITIES L.P. | 145 KING STREET WEST, SUITE 300 <br>11TH FLOOR <br>TORONTO <br>ON ONTARIO <br>MJ5 1J8 CA CANADA |
| GOLDMAN, SACHS & CO. LLC | 222 SOUTH MAIN STREET <br>Attn: Mandatory Corporate Actions <br>SALT LAKE CITY <br>UT UTAH <br>84101 US | HAYWOOD SECURITIES INC./CDS\*\* | 200 BURRARD ST <br>WATERFRONT CENTRE SUITE 700 <br>VANCOUVER <br>BC BRITISH COLUMBIA <br>V6C 3L6 CANADA |
| HILLTOP SECURITIES INC. | 1201 ELM ST. <br>35TH FLOOR <br>DALLAS <br>TX TEXAS <br>75270 US | HRT FINANCIAL LLC | 150 GREENWICH STREET (ATTN: SETTLEMENT) FOUR WORLD TRADE CENTER <br>57TH FLOOR <br>NEW YORK <br>NY NEW YORK <br>10007 US |
| HSBC BANK USA, NA/HSBC CUSTODY & CLEARING SERVICES FOR STOCK LOAN | 452 FIFTH AVENUE <br>ATTN: HBUS CCS SETTS <br>NEW YORK <br>NY NEW YORK <br>10018 US | HSBC BANK USA, NATIONAL ASSOCIATION | 452 FIFTH AVENUE <br>ATTN: HBUS CCS SETTS <br>NEW YORK <br>NEW YORK <br>10018 US |
| INTERACTIVE BROKERS LLC | 2 PICKWICK PLAZA <br>2ND FLOOR <br>GREENWICH <br>CT CONNECTICUT <br>06830 US | J.P. MORGAN CHASE BANK NA/FBO BLACKROCK CTF | 1111 POLARIS PARKWAY <br>COLUMBUS <br>OH OHIO <br>43240 |

---

------

---

| | |
|:---|:---|
| ![LOGO](g452367sp04.jpg) <br>sorrentotherapeutics.com<br>4955 Directors Place<br> San Diego, CA 92121 | ![LOGO](g452367snapb3.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| J.P. MORGAN CLEARING CORP. | FOUR CHASE METROTECH CENTER <br>3RD FLOOR <br>BROOKLYN <br>NY NEW YORK <br>11201 US | JANNEY MONTGOMERY SCOTT LLC | 1717 ARCH STREET <br>17TH FLOOR <br>PHILADELPHIA <br>PA PENNSYLVANIA <br>19103 US |
| JEFFERIES LLC | 101 HUDSON STREET,<br>11th Floor <br>NEW JERSEY <br>NJ NEW JERSEY <br>07302 US | JPMORGAN CHASE BANK, NATIONAL ASSOCIATION | FOUR CHASE METROTECH CENTER <br>3RD FLOOR <br>BROOKLYN <br>NY NEW YORK <br>11201 US |
| JPMORGAN CHASE BANK/EUROCLEAR BANK | FOUR CHASE METROTECH CENTER <br>3RD FLOOR <br>BROOKLYN <br>NY NEW YORK <br>11245 US | JPMORGAN CHASE BANK/IA | FOUR CHASE METROTECH CENTER <br>3RD FLOOR <br>BROOKLYN <br>NY NEW YORK <br>11201 US |
| KEYBANK NATIONAL ASSOCIATION | 4900 TIEDEMAN RD <br>BROOKLYN <br>OH OHIO <br>44144 US | LAURENTIAN BANK SECURITIES INC. | 1981 MCGILL COLLEGE AVE. <br>SUITE 100 <br>MONTREAL <br>QUEBEC <br>H3A 3K3 CA CANADA |
| LPL FINANCIAL LLC | 4707 EXECUTIVE DRIVE <br>SAN DIEGO <br>CA CALIFORNIA <br>92121 US | MANUFACTURERS AND TRADERS TRUST COMPANY | ONE M&T PLAZA <br>TRUST OPS 8TH FLOOR <br>BUFFALO <br>NY NEW YORK <br>14203 US |
| MANULIFE SECURITIES INCORPORATED | 1235 NORTH SERVICE ROAD WEST <br>OAKVILLE <br>ON ONTARIO <br>L6M 2W2 CA CANADA | MARSCO INVESTMENT CORPORATION | 101 EISENHOWER PARKWAY <br>ROSELAND <br>NJ NEW JERSEY <br>07068 US |
| MERRILL LYNCH, PIERCE, FENNER & | 4804 Deer Lake Drive East <br>FL9-803-04-04- 4th floor <br>JACKSONVILLE | MIRAE ASSET SECURITIES (USA) INC./STOCK | 810 SEVENTH AVE <br>37TH FLOOR <br>NEW YORK |

---

------

---

| | |
|:---|:---|
| ![LOGO](g452367sp04.jpg) <br>sorrentotherapeutics.com<br>4955 Directors Place<br> San Diego, CA 92121 | ![LOGO](g452367snapb3.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| SMITH INCORPORATED | FL FLORIDA <br>32246 US | LOAN CONDUIT ACCOUNT | NY NEW YORK <br>10019 |
| MIRAE ASSET SECURITIES (USA), INC. | 810 SEVENTH AVE <br>37TH FLOOR <br>NEW YORK <br>NY NEW YORK <br>10019 | MITSUBISHI UFJ TRUST & BANKING CORPORATION, NEW YORK BRANCH | 280 PARK AVE <br>39TH FL-WEST BLDG <br>NEW YORK <br>NY NEW YORK <br>10017 |
| Morgan Stanley | 1300 THAMES STREET <br>THAMES STREET WHARF <br>BALTIMORE <br>MD MARYLAND <br>21231 US | MORGAN STANLEY & CO. LLC | 1300 THAMES ST. <br>BALTIMORE <br>MD MARYLAND |
| MORGAN STANLEY SMITH BARNEY LLC | 1 NEW YORK PLAZA <br>39TH FLOOR <br>NEW YORK <br>NY NEW YORK <br>10004 US | MURIEL SIEBERT & CO., INC. | 77 SUMMER STREET <br>3RD FLOOR <br>BOSTON <br>MA MASSACHUSETTS <br>02210 US |
| NATIONAL FINANCIAL SERVICES LLC | 499 WASHINGTON BOULEVARD <br>5TH FLOOR <br>JERSEY CITY <br>NJ NEW JERSEY <br>07310 US | NBCN INC. | 1010 rue De La Gauchetière <br>Mezzanine 100 <br>MONTREAL <br>QUEBEC <br>H3B 5J2 CA CANADA |
| NOMURA INTERNATIONAL TRUST COMPANY | 309 WEST 49TH STREET <br>10TH FLOOR <br>NEW YORK <br>NY NEW YORK <br>10019 US | ODLUM BROWN LIMITED | 250 HOWE STREET <br>SUITE 1100 <br>VANCOUVER <br>BC BRITISH COLUMBIA <br>V6C 3R8 CA CANADA |
| OPPENHEIMER & CO. INC. | 85 BROAD STREET <br>NEW YORK <br>NY NEW YORK <br>10004 US | PERSHING LLC | 1 PERSHING PLAZA <br>JERSEY CITY <br>NJ NEW JERSEY <br>07399 US |

---

------

---

| | |
|:---|:---|
| ![LOGO](g452367sp04.jpg) <br>sorrentotherapeutics.com<br>4955 Directors Place<br> San Diego, CA 92121 | ![LOGO](g452367snapb3.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| PHILLIP CAPITAL INC. | 141 W. JACKSON BLVD. SUITE 3050 <br>CHICAGO <br>IL ILLINOIS <br>60604 US | PI FINANCIAL CORP. | 666 BURRARD ST <br>SUITE 1900 <br>VANCOUVER <br>BC BRITISH COLUMBIA <br>V6C 3N1 CA CANADA |
| PNC BANK, NATIONAL ASSOCIATION | 4100 W 150TH STREET <br>ASSET MOVEMENT TEAM 3RD FL, LOCATOR B7-YB17-03-03 <br>CLEVELAND <br>OH OHIO <br>44135 US | PRINCIPAL BANK | 711 HIGH STREET <br>DES MOINES <br>IA IOWA <br>50392 |
| QUESTRADE INC./CDS\*\* | 5650 YONGE ST., <br>Suite 1700 <br>TORONTO <br>ON ONTARIO <br>M2M 4G3 CA CANADA | Raymond James & Associates, Inc. | 880 CARILLON PKWY <br>ST. PETERSBURG <br>FL FLORIDA <br>33733-2749 US |
| RAYMOND JAMES LTD. | 925 WEST GEORGIA STREET <br>SUITE 2200 <br>VANCOUVER <br>BC BRITISH COLUMBIA <br>V6C 3L2 CA CANADA | RBC CAPITAL MARKETS, LLC | 60 SOUTH 6TH ST. <br>MINNEAPOLIS <br>MN MINNESOTA <br>55402 US |
| RBC DOMINION SECURITIES INC | 21 COMMERCE COURT SOUTH <br>2ND FLOOR <br>TORONTO <br>ON ONTARIO <br>M5L 1A7 CANADA | RELIANCE TRUST COMPANY | 1100 ABERNATHY RD. <br>500 NORTHPARK SUITE 400 <br>ATLANTA <br>GA GEORGIA <br>30113 US |
| RELIANCE TRUST COMPANY | 4900 W. BROWN DEER RD <br>MILWAUKEE <br>WI WISCONSIN <br>53223 US | ROBERT W. BAIRD & CO. INCORPORATED | 777 E WISCONSIN AVE <br>9TH FLOOR <br>MILWAUKEE <br>WI WISCONSIN <br>53202 US |

---

------

---

| | |
|:---|:---|
| ![LOGO](g452367sp04.jpg) <br>sorrentotherapeutics.com<br>4955 Directors Place<br> San Diego, CA 92121 | ![LOGO](g452367snapb3.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| ROBINHOOD SECURITIES, LLC | 500 COLONIAL CENTER PARKWAY <br>SUITE 100 <br>LAKE MARY <br>FL FLORIDA <br>32746 US | SAFRA SECURITIES LLC | 546 5TH AVENUE <br>NEW YORK <br>NY NEW YORK <br>10036 US |
| SCOTIA CAPITAL (USA) INC. | 150 KING STREET W <br>5TH FLOOR <br>TORONTO <br>ON ONTARIO <br>M5H 1J9 CA CANADA | SEI PRIVATE TRUST COMPANY | 1 FREEDOM VALLEY DRIVE <br>OAKS <br>PA PENNSYLVANIA <br>19456 US |
| SEI PRIVATE TRUST COMPANY | 1 FREEDOM VALLEY DRIVE <br>OAKS <br>PA PENNSYLVANIA <br>19456 US | SG AMERICAS SECURITIES, LLC | 480 WASHINGTON BLVD. <br>20TH FLOOR <br>JERSEY CITY <br>NJ NEW JERSEY <br>07310 US |
| SSB - BLACKROCK INSTITUTIONAL TRUST | 50 California Street <br>San Francisco <br>CA CALIFORNIA <br>94163 | SSB - TRUST CUSTODY | 30 ADELAIDE ST EAST <br>SUITE 800 <br>TORONTO <br>ON ONTARIO <br>M5C 3G6 CA CANADA |
| SSB&T CO/CLIENT CUSTODY SERVICES | 1776 HERITAGE DRIVE <br>NORTH QUINCY <br>MA MASSACHUSETTS <br>02171 | STATE STREET BANK & TRUST CO | 16 WALL STREET <br>5TH FLOOR <br>NEW YORK <br>NY NEW YORK <br>10005 US |
| STATE STREET BANK & TRUST COMPANY / ISHARES EUROPE | 1776 HERITAGE DRIVE <br>NORTH QUINCY <br>MA MASSACHUSETTS <br>02171 | STATE STREET BANK & TRUST/STATE STREET TOTALETF | 1776 Heritage Drive <br>NORTH QUINCY <br>MA MASSACHUSETTS <br>02717 |
| STATE STREET BANK AND TRUST COMPANY | 30 ADELAIDE ST EAST <br>SUITE 800 <br>TORONTO <br>ON ONTARIO <br>M5C 3G6 CA CANADA | STIFEL, NICOLAUS & COMPANY, INCORPORATED | 501 N BROADWAY <br>ST. LOUIS <br>MO MISSOURI <br>63102 US |

---

------

---

| | |
|:---|:---|
| ![LOGO](g452367sp04.jpg) <br>sorrentotherapeutics.com<br>4955 Directors Place<br> San Diego, CA 92121 | ![LOGO](g452367snapb3.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| STONEX FINANCIAL INC. | 2 PERIMETER PARK SOUTH <br>SUITE 100 W <br>BIRMINGHAM <br>AL ALABAMA <br>35243 US | TD AMERITRADE CLEARING, INC. | 200 S 108TH AVE <br>OMAHA <br>NE NEBRASKA <br>68154 US |
| TD WATERHOUSE CANADA INC <br>ATTN: MANDATORY CORPORATE ACTIONS | 77 BLOOR STREET WEST <br>3RD FLOOR <br>TORONTO <br>ON ONTARIO <br>M5S 1M2 CA CANADA | TEXAS TREASURY SAFEKEEPING TRUST COMPANY | 208 E 10TH ST <br>AUSTIN <br>TX TEXAS <br>78701 US |
| THE BANK OF NEW YORK MELLON | 500 GRANT STREET <br>27TH FLOOR <br>PITTSBURGH <br>PA PENNSYLVANIA <br>15258 US | THE HUNTINGTON NATIONAL BANK | 7 EASTON OVAL EA4E62 <br>COLUMBUS <br>OH OHIO <br>43209 US |
| THE NORTHERN TRUST COMPANY | 333 South Wabash Ave, 32nd Floor <br>Attn: Trade Securities Processing <br>CHICAGO <br>IL ILLINOIS <br>60603 US | TRADESTATION SECURITIES, INC. | 120 RIVERSIDE PLAZA <br>SUITE 1650 <br>CHICAGO <br>IL ILLINOIS <br>60606 US |
| U.S. BANCORP INVESTMENTS, INC. | 60 LIVINGSTON AVE <br>EP-MN-WN1B <br>ST. PAUL <br>MN MINNESOTA <br>55107-1419 US | U.S. BANK N.A./ETF | 1555 N RIVER CENTER DRIVE <br>MILWAUKEE <br>WI WISCONSIN <br>53212 |
| U.S. BANK NATIONAL ASSOCIATION | 1555 NORTH RIVERCENTER DRIVE, SUITE 302 <br>SUITE 302 <br>MILWAUKEE <br>WI WISCONSIN <br>53212 US | UBS AG | 480 WASHINGTON BLVD. <br>12TH FLOOR <br>JERSEY CITY <br>NJ NEW JERSEY <br>07310 US |

---

------

---

| | |
|:---|:---|
| ![LOGO](g452367sp04.jpg) <br>sorrentotherapeutics.com<br>4955 Directors Place<br> San Diego, CA 92121 | ![LOGO](g452367snapb3.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| UBS FINANCIAL SERVICES INC. | 1000 HARBOR BOULEVARD <br>WEEHAWKEN <br>NJ NEW JERSEY <br>07086 US | UBS SECURITIES LLC | 677 WASHINGTON BLVD <br>STAMFORD <br>CT CONNECTICUT <br>06901 US |
| UMB BANK, NATIONAL ASSOCIATION | 928 GRAND BLVD <br>KANSAS CITY <br>MO MISSOURI <br>64106 US | VANGUARD MARKETING CORPORATION | 100 VANGUARD BLVD <br>MALVERN <br>PA PENNSYLVANIA <br>19355 US |
| VELOCITY CLEARING, LLC | 1301 Route 36 <br>Suite 109 (Attn: Chris Felicetti) <br>HAZLET <br>NEW JERSEY <br>7730 US | VELOX CLEARING LLC | 2400 E. KATELLA AVENUE <br>SUITE 725A <br>ANAHEIM <br>CA CALIFORNIA <br>92806 US |
| VIRTU AMERICAS LLC | ONE LIBERTY PLAZA, 165 BROADWAY <br>5TH FLOOR <br>NEW YORK <br>NY NEW YORK <br>10006 US | VISION FINANCIAL MARKETS LLC | 4 HIGH RIDGE PARK <br>SUITE 100 <br>STAMFORD <br>CT CONNECTICUT <br>06905 US |
| WEDBUSH SECURITIES INC | 1000 WILSHIRE BLVD <br>8TH FLOOR <br>LOS ANGELES <br>CA CALIFORNIA <br>90017 US | WEDBUSH SECURITIES INC. | 1000 WILSHIRE BLVD. <br>LOS ANGELES <br>CA CALIFORNIA <br>90017 US |
| WELLS FARGO BANK, N.A./SIG | 733 MARQUETTE AVE 4TH FLOOR <br>MAC N9306-04D <br>MINNEAPOLIS <br>MN MINNESOTA <br>55402 US | WELLS FARGO CLEARING SERVICES LLC | 1 NORTH JEFFERSON <br>MAIL CODE: H0006-094 <br>ST. LOUIS <br>MO MISSOURI <br>63103 US |
| WELLS FARGO SECURITIES, LLC | 1525 WEST W T HARRIS BLVD <br>CHARLOTTE <br>NC NORTH CAROLINA <br>28262 US | WILSON-DAVIS & CO., INC. | 236 SOUTH MAIN STREET <br>SALT LAKE CITY <br>UT UTAH <br>84101 US |

---

------

**Exhibit 99.2**![LOGO](g452367g0201205527357.jpg)

**FOR IMMEDIATE RELEASE** 

**February 2, 2023** 

**Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued "FAQ" Regarding the Dividend of Scilex Holding Company Common Stock** 

PALO ALTO, February 2, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today posted a supplement to its previously issued "Frequently Asked Questions" document under the "Investors" section of its website at <u>www.sorrentotherapeutics.com</u> regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company held by Sorrento.

The supplement to the FAQs provides notice regarding the Depository Trust and Clearing Corporation's removal of the contra-CUSIP on Scilex common stock that was distributed as a dividend to Sorrento's stockholders and provides notice to brokerage firms, banks, dealers and similar organizations listed therein that a dividend confirmation had previously been distributed to such firms by Scilex's transfer agent and requests that such firms contact Scilex's transfer agent if they have not received such confirmation. The supplement also reiterates a question related to issues that may arise with respect to the dividend in connection with short positions in Sorrento common stock.

The supplement to the FAQs and related annex are included in this press release and can also be found Scilex's website <u>https://www.scilexholding.com/investors/faqs/</u>

**SUPPLEMENT TO** 

**FREQUENTLY ASKED QUESTIONS** 

**REGARDING THE DIVIDEND OF SCILEX HOLDING COMPANY COMMON STOCK BY SORRENTO THERAPEUTICS, INC.** 

This supplement is a supplement to the Frequently Asked Questions Regarding the Dividend of Scilex Holding Company Common Stock by Sorrento Therapeutics, Inc. (<u>Sorrento</u>) that was issued by Sorrento on January 29, 2023 (the <u>FAQ</u>), a copy of which can be found under the "Investors" section of its website at <u>www.sorrentotherapeutics.com</u>.

This supplement is being issued to update and supplement the information in the FAQ to notify investors regarding certain matters relating to the dividend and reiterate certain questions and answers from the FAQ. Capitalized terms used in this supplement shall have their respective meetings set forth in the FAQ.

------

**NOTICE OF REMOVAL OF CONTRA-CUSIP BY DTCC** 

**Effective as of February 2, 2023, the Depository Trust and Clearing Corporation has removed the "contra-CUSIP" that it had previously imposed on the Dividend Stock. Any shares of Dividend Stock held by your brokerage firm, bank, dealer or other similar organization for your benefit now bear only Scilex's CUSIP number, which is 80880W106. If you are entitled to receive Dividend Stock,** 

------

 **please contact your brokerage firm, bank, or other similar organization immediately to confirm that the CUSIP number appears on your brokerage statement with respect to your Dividend Stock.** 

------

**NOTICE TO BROKERAGE FIRMS, BANKS, DEALERS AND OTHER SIMILAR ORGANIZATIONS** 

**If the name of your firm, bank or other similar organization is set forth on Annex B of the FAQ, which Annex B is repeated below for convenience, and your firm, bank or similar organization has not received the Dividend Confirmation that was mailed to your firm, bank or similar organization, please contact Scilex's transfer agent immediately to obtain a copy of the Dividend Confirmation. Scilex's transfer agent's contact information is as follows:** 

**Continental Stock Transfer & Trust Company** 

**Telephone Number**: 800-509-5586

**Email Address**: cstmail@continentalstock.com

**Several major brokers have confirmed to Sorrento and Scilex that they are adding the Scilex share positions to the individual brokerage accounts of Sorrento shareholders receiving the Dividend Stock.** 

------

**SUPPLEMENTAL QUESTION AND ANSWER** 

---

| | |
|:---|:---|
| **Q:** | **If I loaned my shares of Sorrento common stock to short sellers or any other party as of the Record Date, am I still entitled to receive Dividend Stock as of the Payment Date?** |
| A: | Only Record Holders as of the Record Date are entitled to receive the Dividend Stock. If you were the Record Holder as of the Record Date and are entitled to receive the Dividend Stock, but have not received the Dividend Stock, you may be entitled to receive Dividend Stock from the short seller or other party who borrowed your shares of Sorrento common stock, whether through the lending programs implemented by your brokerage firm, bank, dealer and other similar organization or otherwise. **If you were a Record Holder as of the Record Date and have not received your Dividend Stock, please consult with your financial advisor, broker or other agent immediately to determine how to receive your Dividend Stock.** |

---

------

**Annex B** 

**Broker List** 

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| ABN AMRO CLEARING CHICAGO LLC | 175 WEST JACKSON BLVD.<br> CHICAGO<br> IL ILLINOIS<br> 60604 US | Albert Fried &<br> Company LLC | 45 BROADWAY, 24TH FLOOR<br> 24TH FLOOR<br> NEW YORK<br> NY NEW YORK<br> 10006 US |
| AMALGAMATED BANK | 275 7TH AVENUE<br> NEW YORK<br> NY NEW YORK<br> 10003 US | AMERICAN ENTERPRISE INVESTMENT SERVICES INC. | 682 AMERIPRISE FINANCIAL CENTER<br> MINNEAPOLIS<br> MN MINNESOTA<br> 55474 US |
| APEX CLEARING CORPORATION | 2 GATEWAY CENTER 283-299 MARKET ST<br> 16TH FLOOR<br> NEWARK<br> NJ NEW JERSEY<br> 07102-5005 US | BANK OF AMERICA, NA/GWIM TRUST OPERATIONS | 901 MAIN STREET<br> 12TH FLOOR<br> DALLAS<br> TX TEXAS<br> 23113 US |
| BANK OF NEW YORK MELLON | 111 SANDERS CREEK PARKWAY<br> 2ND FLOOR<br> 2ND FLOOR<br> EAST SYRACUSE<br> NY NEW YORK<br> 13057 US. | BARCLAYS CAPITAL INC. | DTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS-MILLER OR ROBERT MENDEZ<br> JERSEY CITY<br> NJ NEW JERSEY<br> 07310 US |
| BARCLAYS CAPITAL INC. | DTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS-MILLER OR ROBERT MENDEZ<br> JERSEY CITY<br> NJ NEW JERSEY<br> 07310 US | BMO CAPITAL MARKETS CORP. | 3 2ND STREET<br> 12TH FLOOR<br> JERSEY CITY<br> NJ NEW JERSEY<br> 07302 US |
| BMO HARRIS BANK NA/TRUST | 11270 W PARK PL<br> MILWAUKEE<br> WI WISCONSIN<br> 53224 US | BMO Nesbitt Burns Inc., Toronto | 250 YONGE STREET, 7TH FLOOR<br> 7TH FLOOR<br> TORONTO<br> ON ONTARIO<br> M5B 2M8 CA CANADA |

---

------

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| BNP PARIBAS, NEW YORK BRANCH/BNP PARIBAS PRIME BROKERAGE CUSTODIAN | 100 WEST 33RD STREET<br> 3RD FLOOR<br> NEW YORK<br> NY NEW YORK<br> 10001 | BNP PARIBAS, NEW YORK BRANCH/BNP PARIBAS PRIME BROKERAGE CUSTODIAN | 100 WEST 33RD STREET<br> 3RD FLOOR<br> NEW YORK<br> NY NEW YORK<br> 10001 |
| BNY MELLON | PO BOX 392002<br> 500 ROSS STREET<br> PITTSBURGH<br> PA PENNSYLVANIA<br> 15262 US | BNY MELLON/WEALTH MANAGEMENT | 1 FREEDOM VALLEY DRIVE<br> OAKS<br> PA PENNSYLVANIA<br> 19456 US |
| BNYMELLON | 111 SANDERS CREEK PARKWAY 2ND FLOOR<br> 2ND FLOOR<br> EAST SYRACUSE<br> NY NEW YORK<br> 13057 US | BNYMELLON/RE BARCLAYS CAPITAL SECURITIES LTD. | ONE WALL STREET<br> NEW YORK<br> NY NEW YORK<br> 10286 |
| BNYMELLON/RE CACEIS BANK LUXEMBOURG | 500 Grant St.<br> BNY Mellon Center<br> PITTSBURGH<br> PA PENNSYLVANIA<br> 15258 | BNYMELLON/RE CACEIS BANK, NETHERLANDS | 111 SANDERS CREEK PARKWAY<br> EAST SYRACUSE<br> NY NEW YORK<br> 13057 |
| BNYMELLON/RE CHARLES STANLEY AND COMPANY, LIMITED | 111 SANDERS CREEK PARKWAY 2ND FLOOR<br> 2ND FLOOR<br> EAST SYRACUSE<br> NY NEW YORK<br> 13057 US | BNYMELLON/RE ETF - ISHARES DTC/NSCC | 111 SANDERS CREEK PARKWAY<br> EAST SYRACUSE<br> NY NEW YORK<br> 13057 |
| BNYMELLON/RE WINTERFLOOD SECURITIES LTD | 500 Grant St.<br> BNY Mellon Center<br> PITTSBURGH<br> PA PENNSYLVANIA<br> 15258 | BOFA | 4804 Deer Lake Drive East<br> FL9-803-04-04- 4th floor<br> JACKSONVILLE<br> FL FLORIDA<br> 32246 US |
| BOFA | 4804 Deer Lake Drive East<br> FL9-803-04-04- 4th floor<br> JACKSONVILLE<br> FL FLORIDA<br> 32246 US | BOFA SECURITIES INC | 4804 Deer Lake Drive East<br> FL9-803-04-04- 4th floor<br> JACKSONVILLE<br> FL FLORIDA<br> 32246 US |

---

------

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| BROWN BROTHERS HARRIMAN & CO. | 140 BROADWAY<br> ATTN: CORPORATE ACTIONS VAULT<br> NEW YORK<br> NY NEW YORK<br> 10005 US | BROWN BROTHERS HARRIMAN & CO./ETF | 140 BROADWAY<br> NEW YORK<br> NY NEW YORK<br> 10005 |
| CALDWELL SECURITIES LTD./CDS\*\* | 55 UNIVERSITY AVENUE<br> SUITE 340<br> TORONTO<br> ON ONTARIO<br> M5J 2H7 CANADA | CANACCORD GENUITY CORP. | 609 GRANVILLE ST<br> VANCOUVER<br> BC BRITISH COLUMBIA<br> V7Y 1H2 CA CANADA |
| CANTOR, FITZGERALD & CO. | 135 E 57TH ST 5TH FL<br> NEW YORK<br> NY NEW YORK<br> 10041 US | CDS CLEARING AND DEPOSITORY SERVICES INC. | 100 ADELAIDE STREET WEST<br> TORONTO<br> ON ONTARIO<br> M5H 1S3 CA CANADA |
| CETERA INVESTMENT SERVICES LLC | 400 FIRST STREET SOUTH, SUITE 300<br> SUITE 300<br> ST. CLOUD<br> MN MINNESOTA<br> 56302-0283 US | CHARLES SCHWAB & CO., INC. | 211 MAIN STREET<br> SAN FRANCISCO<br> CA CALIFORNIA<br> 94105 US |
| CI INVESTMENT SERVICES INC. | 199 BAY STREET<br> SUITE 2600<br> TORONTO<br> ON ONTARIO<br> M5L 1E2 CA CANADA | CIBC WORLD MARKETS INC./CDS\*\* | 161 BAY STREET 10 FL<br> TORONTO<br> ON ONTARIO<br> M5J 2S8 CA CANADA |
| CITIBANK, N.A./ETF | 3800 CITIGROUP CENTER<br> B2/2<br> TAMPA<br> FL FLORIDA<br> 33610 | CITIBANK, NATIONAL ASSOCIATION | 3800 CITIBANK CENTER TAMPA<br> BLDG.B FIRST FLOOR ZONE 8<br> TAMPA<br> FL FLORIDA<br> 33610-9122 US |
| CITIGROUP GLOBAL MARKETS, INC. | 580 CROSSPOINT PARKWAY<br> GETZVILLE<br> NY NEW YORK<br> 14068 US | CLEAR STREET LLC | 4 World Trade Center, 45th Floor<br> 150 Greenwich Street<br> NEW YORK<br> NY NEW YORK<br> 10007 |
| CLEARSTREET IO | 55 BROADWAY (SUITE 2102)<br> CORPORATE ACTIONS<br> NEW YORK<br> NEW YORK<br> 10006 US | COMMERCE BANK | 922 WALNUT STREET<br> MAIL STOP TBTS-2<br> KANSAS CITY<br> MO MISSOURI<br> 64106 US |

---

------

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| COR CLEARING LLC | 9300 UNDERWOOD AVE<br> SUITE 400<br> OMAHA<br> NE NEBRASKA<br> 68114 US | Credential Securities Inc. | 800-1111 WEST GEORGIA STREET<br> VANCOUVER<br> BC BRITISH COLUMBIA<br> V6E 4T6 CA CANADA |
| CREST INTERNATIONAL NOMINEES LIMITED | 33 CANNON STREET<br> LONDON<br> EC4M 5SB GB UNITED KINGDO | CURVATURE SECURITIES, LLC | 39 MAIN STREET<br> CHATHAM<br> NJ NEW JERSEY<br> 07928 US |
| D.A. DAVIDSON & CO. | 8 3RD STREET NORTH<br> GREAT FALLS<br> MT MONTANA<br> 59401 US | DEPOSITO CENTRAL DE VALORES S.A., DEPOSITO DE VALORES | AVENIDA APOQUINDO # 4001<br> FLOOR 12, C.P.<br> 7550162, SANTIAGO<br> CL CHILE |
| DESJARDINS SECURITIES INC. | 1253 McGill College<br> 10TH FLOOR<br> MONTREAL<br> QUEBEC<br> H3B 2Y5 CA CANADA | DEUTSCHE BANK AG NY/US CUSTODY | 1251 Avenue Of The Americas<br> NEW YORK<br> NY NEW YORK<br> 10020 |
| DEUTSCHE BANK SECURITIES INC. | 60 WALL STREET<br> 9TH FLOOR<br> NEW YORK<br> NY NEW YORK<br> 10005 US | DRIVEWEALTH, LLC | 15 EXCHANGE PLACE<br> 10TH FLOOR<br> JERSEY CITY<br> NEW JERSEY<br> 07302 |
| E\*TRADE CLEARING LLC | HARBORSIDE FINANCIAL CENTER<br> 501 PLAZA 11<br> JERSEY CITY<br> NJ NEW JERSEY<br> 07311 US | EDWARD D. JONES & CO., L.P. | 12555 MANCHESTER ROAD<br> ST. LOUIS<br> MO MISSOURI<br> 63131-3729 US |
| EDWARD D. JONES & CO., L.P. | 201 PROGRESS PARKWAY<br> MARYLAND HEIGHTS<br> MO MISSOURI<br> 63043 US | FIDELITY CLEARING CANADA ULC/CDS\*\* | 483 BAY ST.<br> SOUTH TOWER<br> TORONTO<br> ON ONTARIO<br> M5G2N7 CA CANADA |

---

------

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| FIFTH THIRD BANK | 5001 KINGSLEY DRIVE<br> MAIL DROP 1MOB28<br> CINCINNATI<br> OH OHIO<br> 45227 US | FOLIO INVESTMENTS, INC. | 8180 GREENSBORO DRIVE<br> 8TH FLOOR<br> MCLEAN<br> VA VIRGINIA<br> 22102 US |
| FUTU CLEARING INC. | 12750 Merit Drive<br> SUITE 475<br> DALLAS<br> TX TEXAS<br> 75251 | GMP SECURITIES L.P. | 145 KING STREET WEST, SUITE 300<br> 11TH FLOOR<br> TORONTO<br> ON ONTARIO<br> MJ5 1J8 CA CANADA |
| GOLDMAN, SACHS & CO. LLC | 222 SOUTH MAIN STREET<br> Attn: Mandatory Corporate Actions<br> SALT LAKE CITY<br> UT UTAH<br> 84101 US | HAYWOOD SECURITIES INC./CDS\*\* | 200 BURRARD ST<br> WATERFRONT CENTRE SUITE 700<br> VANCOUVER<br> BC BRITISH COLUMBIA<br> V6C 3L6 CANADA |
| HILLTOP SECURITIES INC. | 1201 ELM ST.<br> 35TH FLOOR<br> DALLAS<br> TX TEXAS<br> 75270 US | HRT FINANCIAL LLC | 150 GREENWICH STREET (ATTN: SETTLEMENT) FOUR WORLD TRADE CENTER<br> 57TH FLOOR<br> NEW YORK<br> NY NEW YORK<br> 10007 US |
| HSBC BANK USA, NA/HSBC CUSTODY & CLEARING SERVICES FOR STOCK LOAN | 452 FIFTH AVENUE<br> ATTN: HBUS CCS SETTS<br> NEW YORK<br> NY NEW YORK<br> 10018 US | HSBC BANK USA, NATIONAL ASSOCIATION | 452 FIFTH AVENUE<br> ATTN: HBUS CCS SETTS<br> NEW YORK<br> NEW YORK<br> 10018 US |
| INTERACTIVE BROKERS LLC | 2 PICKWICK PLAZA<br> 2ND FLOOR<br> GREENWICH<br> CT CONNECTICUT<br> 06830 US | J.P. MORGAN CHASE BANK NA/FBO BLACKROCK CTF | 1111 POLARIS PARKWAY<br> COLUMBUS<br> OH OHIO<br> 43240 |
| J.P. MORGAN CLEARING CORP. | FOUR CHASE METROTECH CENTER<br> 3RD FLOOR<br> BROOKLYN<br> NY NEW YORK<br> 11201 US | JANNEY MONTGOMERY SCOTT LLC | 1717 ARCH STREET<br> 17TH FLOOR<br> PHILADELPHIA<br> PA PENNSYLVANIA<br> 19103 US |

---

------

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| JEFFERIES LLC | 101 HUDSON STREET, 11th Floor<br> NEW JERSEY<br> NJ NEW JERSEY<br> 07302 US | JPMORGAN CHASE BANK, NATIONAL ASSOCIATION | FOUR CHASE METROTECH CENTER<br> 3RD FLOOR<br> BROOKLYN<br> NY NEW YORK<br> 11201 US |
| JPMORGAN CHASE BANK/EUROCLEAR BANK | FOUR CHASE METROTECH CENTER<br> 3RD FLOOR<br> BROOKLYN<br> NY NEW YORK<br> 11245 US | JPMORGAN CHASE BANK/IA | FOUR CHASE METROTECH CENTER<br> 3RD FLOOR<br> BROOKLYN<br> NY NEW YORK<br> 11201 US |
| KEYBANK NATIONAL ASSOCIATION | 4900 TIEDEMAN RD<br> BROOKLYN<br> OH OHIO<br> 44144 US | LAURENTIAN BANK SECURITIES INC. | 1981 MCGILL COLLEGE AVE.<br> SUITE 100<br> MONTREAL<br> QUEBEC<br> H3A 3K3 CA CANADA |
| LPL FINANCIAL LLC | 4707 EXECUTIVE DRIVE<br> SAN DIEGO<br> CA CALIFORNIA<br> 92121 US | MANUFACTURERS AND TRADERS TRUST COMPANY | ONE M&T PLAZA<br> TRUST OPS 8TH FLOOR<br> BUFFALO<br> NY NEW YORK<br> 14203 US |
| MANULIFE SECURITIES INCORPORATED | 1235 NORTH SERVICE ROAD WEST<br> OAKVILLE<br> ON ONTARIO<br> L6M 2W2 CA CANADA | MARSCO INVESTMENT CORPORATION | 101 EISENHOWER PARKWAY<br> ROSELAND<br> NJ NEW JERSEY<br> 07068 US |
| MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED | 4804 Deer Lake Drive East<br> FL9-803-04-04- 4th floor<br> JACKSONVILLE<br> FL FLORIDA<br> 32246 US | MIRAE ASSET SECURITIES (USA) INC./STOCK LOAN CONDUIT ACCOUNT | 810 SEVENTH AVE<br> 37TH FLOOR<br> NEW YORK<br> NY NEW YORK<br> 10019 |
| MIRAE ASSET SECURITIES (USA), INC. | 810 SEVENTH AVE<br> 37TH FLOOR<br> NEW YORK<br> NY NEW YORK<br> 10019 | MITSUBISHI UFJ TRUST & BANKING CORPORATION, NEW YORK BRANCH | 280 PARK AVE<br> 39TH FL-WEST BLDG<br> NEW YORK<br> NY NEW YORK<br> 10017 |

---

------

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| Morgan Stanley | 1300 THAMES STREET<br> THAMES STREET WHARF<br> BALTIMORE<br> MD MARYLAND<br> 21231 US | MORGAN STANLEY & CO. LLC | 1300 THAMES ST.<br> BALTIMORE<br> MD MARYLAND |
| MORGAN STANLEY SMITH BARNEY LLC | 1 NEW YORK PLAZA<br> 39TH FLOOR<br> NEW YORK<br> NY NEW YORK<br> 10004 US | MURIEL SIEBERT & CO., INC. | 77 SUMMER STREET<br> 3RD FLOOR<br> BOSTON<br> MA MASSACHUSETTS<br> 02210 US |
| NATIONAL FINANCIAL SERVICES LLC | 499 WASHINGTON BOULEVARD<br> 5TH FLOOR<br> JERSEY CITY<br> NJ NEW JERSEY<br> 07310 US | NBCN INC. | 1010 rue De La Gauchetière<br> Mezzanine 100<br> MONTREAL<br> QUEBEC<br> H3B 5J2 CA CANADA |
| NOMURA INTERNATIONAL TRUST COMPANY | 309 WEST 49TH STREET<br> 10TH FLOOR<br> NEW YORK<br> NY NEW YORK<br> 10019 US | ODLUM BROWN LIMITED | 250 HOWE STREET<br> SUITE 1100<br> VANCOUVER<br> BC BRITISH COLUMBIA<br> V6C 3R8 CA CANADA |
| OPPENHEIMER & CO. INC. | 85 BROAD STREET<br> NEW YORK<br> NY NEW YORK<br> 10004 US | PERSHING LLC | 1 PERSHING PLAZA<br> JERSEY CITY<br> NJ NEW JERSEY<br> 07399 US |
| PHILLIP CAPITAL INC. | 141 W. JACKSON BLVD. SUITE 3050<br> CHICAGO<br> IL ILLINOIS<br> 60604 US | PI FINANCIAL CORP. | 666 BURRARD ST<br> SUITE 1900<br> VANCOUVER<br> BC BRITISH COLUMBIA<br> V6C 3N1 CA CANADA |
| PNC BANK, NATIONAL ASSOCIATION | 4100 W 150TH STREET<br> ASSET MOVEMENT TEAM 3RD FL, LOCATOR B7-YB17-03-03<br> CLEVELAND<br> OH OHIO<br> 44135 US | PRINCIPAL BANK | 711 HIGH STREET<br> DES MOINES<br> IA IOWA<br> 50392 |
| QUESTRADE INC./CDS\*\* | 5650 YONGE ST.,<br> Suite 1700<br> TORONTO<br> ON ONTARIO<br> M2M 4G3 CA CANADA | Raymond James & Associates, Inc. | 880 CARILLON PKWY<br> ST. PETERSBURG<br> FL FLORIDA<br> 33733-2749 US |

---

------

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| RAYMOND JAMES LTD. | 925 WEST GEORGIA STREET<br> SUITE 2200<br> VANCOUVER<br> BC BRITISH COLUMBIA<br> V6C 3L2 CA CANADA | RBC CAPITAL MARKETS, LLC | 60 SOUTH 6TH ST.<br> MINNEAPOLIS<br> MN MINNESOTA<br> 55402 US |
| RBC DOMINION SECURITIES INC | 21 COMMERCE COURT SOUTH<br> 2ND FLOOR<br> TORONTO<br> ON ONTARIO<br> M5L 1A7 CANADA | RELIANCE TRUST COMPANY | 1100 ABERNATHY RD.<br> 500 NORTHPARK SUITE 400<br> ATLANTA<br> GA GEORGIA<br> 30113 US |
| RELIANCE TRUST COMPANY | 4900 W. BROWN DEER RD<br> MILWAUKEE<br> WI WISCONSIN<br> 53223 US | ROBERT W. BAIRD & CO. INCORPORATED | 777 E WISCONSIN AVE<br> 9TH FLOOR<br> MILWAUKEE<br> WI WISCONSIN<br> 53202 US |
| ROBINHOOD SECURITIES, LLC | 500 COLONIAL CENTER PARKWAY<br> SUITE 100<br> LAKE MARY<br> FL FLORIDA<br> 32746 US | SAFRA SECURITIES LLC | 546 5TH AVENUE<br> NEW YORK<br> NY NEW YORK<br> 10036 US |
| SCOTIA CAPITAL (USA) INC. | 150 KING STREET W<br> 5TH FLOOR<br> TORONTO<br> ON ONTARIO<br> M5H 1J9 CA CANADA | SEI PRIVATE TRUST COMPANY | 1 FREEDOM VALLEY DRIVE<br> OAKS<br> PA PENNSYLVANIA<br> 19456 US |
| SEI PRIVATE TRUST COMPANY | 1 FREEDOM VALLEY DRIVE<br> OAKS<br> PA PENNSYLVANIA<br> 19456 US | SG AMERICAS SECURITIES, LLC | 480 WASHINGTON BLVD.<br> 20TH FLOOR<br> JERSEY CITY<br> NJ NEW JERSEY<br> 07310 US |

---

------

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| SSB - BLACKROCK INSTITUTIONAL TRUST | 50 California Street<br> San Francisco<br> CA CALIFORNIA<br> 94163 | SSB - TRUST CUSTODY | 30 ADELAIDE ST EAST<br> SUITE 800<br> TORONTO<br> ON ONTARIO<br> M5C 3G6 CA CANADA |
| SSB&T CO/CLIENT CUSTODY SERVICES | 1776 HERITAGE DRIVE<br> NORTH QUINCY<br> MA MASSACHUSETTS<br> 02171 | STATE STREET BANK & TRUST CO | 16 WALL STREET<br> 5TH FLOOR<br> NEW YORK<br> NY NEW YORK<br> 10005 US |
| STATE STREET BANK & TRUST COMPANY / ISHARES EUROPE | 1776 HERITAGE DRIVE<br> NORTH QUINCY<br> MA MASSACHUSETTS<br> 02171 | STATE STREET BANK & TRUST/STATE STREET TOTALETF | 1776 Heritage Drive<br> NORTH QUINCY<br> MA MASSACHUSETTS<br> 02717 |
| STATE STREET BANK AND TRUST COMPANY | 30 ADELAIDE ST EAST<br> SUITE 800<br> TORONTO<br> ON ONTARIO<br> M5C 3G6 CA CANADA | STIFEL, NICOLAUS & COMPANY, INCORPORATED | 501 N BROADWAY<br> ST. LOUIS<br> MO MISSOURI<br> 63102 US |
| STONEX FINANCIAL INC. | 2 PERIMETER PARK SOUTH<br> SUITE 100 W<br> BIRMINGHAM<br> AL ALABAMA<br> 35243 US | TD AMERITRADE CLEARING, INC. | 200 S 108TH AVE<br> OMAHA<br> NE NEBRASKA<br> 68154 US |
| TD WATERHOUSE CANADA INC<br> ATTN: MANDATORY CORPORATE ACTIONS | 77 BLOOR STREET WEST<br> 3RD FLOOR<br> TORONTO<br> ON ONTARIO<br> M5S 1M2 CA CANADA | TEXAS TREASURY SAFEKEEPING TRUST COMPANY | 208 E 10TH ST<br> AUSTIN<br> TX TEXAS<br> 78701 US |
| THE BANK OF NEW YORK MELLON | 500 GRANT STREET<br> 27TH FLOOR<br> PITTSBURGH<br> PA PENNSYLVANIA<br> 15258 US | THE HUNTINGTON NATIONAL BANK | 7 EASTON OVAL EA4E62<br> COLUMBUS<br> OH OHIO<br> 43209 US |

---

------

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| THE NORTHERN TRUST COMPANY | 333 South Wabash Ave, 32nd Floor<br> Attn: Trade Securities Processing<br> CHICAGO<br> IL ILLINOIS<br> 60603 US | TRADESTATION SECURITIES, INC. | 120 RIVERSIDE PLAZA<br> SUITE 1650<br> CHICAGO<br> IL ILLINOIS<br> 60606 US |
| U.S. BANCORP INVESTMENTS, INC. | 60 LIVINGSTON AVE<br> EP-MN-WN1B<br> ST. PAUL<br> MN MINNESOTA<br> 55107-1419 US | U.S. BANK N.A./ETF | 1555 N RIVER CENTER DRIVE<br> MILWAUKEE<br> WI WISCONSIN<br> 53212 |
| U.S. BANK NATIONAL ASSOCIATION | 1555 NORTH RIVERCENTER DRIVE, SUITE 302<br> SUITE 302<br> MILWAUKEE<br> WI WISCONSIN<br> 53212 US | UBS AG | 480 WASHINGTON BLVD.<br> 12TH FLOOR<br> JERSEY CITY<br> NJ NEW JERSEY<br> 07310 US |
| UBS FINANCIAL SERVICES INC. | 1000 HARBOR BOULEVARD<br> WEEHAWKEN<br> NJ NEW JERSEY<br> 07086 US | UBS SECURITIES LLC | 677 WASHINGTON BLVD<br> STAMFORD<br> CT CONNECTICUT<br> 06901 US |
| UMB BANK, NATIONAL ASSOCIATION | 928 GRAND BLVD<br> KANSAS CITY<br> MO MISSOURI<br> 64106 US | VANGUARD MARKETING CORPORATION | 100 VANGUARD BLVD<br> MALVERN<br> PA PENNSYLVANIA<br> 19355 US |
| VELOCITY CLEARING, LLC | 1301 Route 36<br> Suite 109 (Attn: Chris Felicetti)<br> HAZLET<br> NEW JERSEY<br> 7730 US | VELOX CLEARING LLC | 2400 E. KATELLA AVENUE<br> SUITE 725A<br> ANAHEIM<br> CA CALIFORNIA<br> 92806 US |
| VIRTU AMERICAS LLC | ONE LIBERTY PLAZA, 165 BROADWAY<br> 5TH FLOOR<br> NEW YORK<br> NY NEW YORK<br> 10006 US | VISION FINANCIAL MARKETS LLC | 4 HIGH RIDGE PARK<br> SUITE 100<br> STAMFORD<br> CT CONNECTICUT<br> 06905 US |
| WEDBUSH SECURITIES INC | 1000 WILSHIRE BLVD<br> 8TH FLOOR<br> LOS ANGELES<br> CA CALIFORNIA<br> 90017 US | WEDBUSH SECURITIES INC. | 1000 WILSHIRE BLVD.<br> LOS ANGELES<br> CA CALIFORNIA<br> 90017 US |

---

------

---

| | | | |
|:---|:---|:---|:---|
| **Broker Name** | **Broker Address** | **Broker Name** | **Broker Address** |
| WELLS FARGO BANK, N.A./SIG | 733 MARQUETTE AVE 4TH FLOOR<br> MAC N9306-04D<br> MINNEAPOLIS<br> MN MINNESOTA<br> 55402 US | WELLS FARGO CLEARING SERVICES LLC | 1 NORTH JEFFERSON<br> MAIL CODE: H0006-094<br> ST. LOUIS<br> MO MISSOURI<br> 63103 US |
| WELLS FARGO SECURITIES, LLC | 1525 WEST W T HARRIS BLVD<br> CHARLOTTE<br> NC NORTH CAROLINA<br> 28262 US | WILSON-DAVIS & CO., INC. | 236 SOUTH MAIN STREET<br> SALT LAKE CITY<br> UT UTAH<br> 84101 US |

---

**About Scilex Holding Company**

Scilex Holding Company, a majority-owned by Sorrento Therapeutics, Inc., is an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Scilex is uncompromising in its focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life. Results from the Phase III Pivotal Trial C.L.E.A.R Program for SEMDEXA<sup>TM</sup>, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022. Scilex has applied for breakthrough therapy designation and expects to seek priority review for SEMDEXA<sup>TM</sup> for the treatment of sciatica. Scilex targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with moderate to severe pain. Scilex launched its first commercial product in October 2018, in-licensed a commercial product in June 2022, and is developing its late-stage pipeline, which includes a pivotal Phase 3 candidate and one Phase 2 and one Phase 1 candidate. Its commercial product, ZTlido<sup>®</sup> (lidocaine topical system) 1.8%, or ZTlido<sup>®</sup>, is a prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. Scilex in-licensed the exclusive right to commercialize Gloperba<sup>®</sup> (colchicine USP) oral solution, an FDA-approved prophylactic treatment for painful gout flares in adults, in the U.S. Scilex is planning to commercialize Gloperba<sup>®</sup> in 2023 and is well-positioned to market and distribute the product. Scilex's three product candidates are SP-102 (injectable dexamethasone sodium phosphate viscous gel product containing 10 mg dexamethasone), or SEMDEXA<sup>™</sup>, a Phase 3, novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, with FDA Fast Track status; SP-103 (lidocaine topical system) 5.4%, a Phase 2, triple-strength formulation of ZTlido<sup>®</sup>, for the treatment of low back pain, with FDA Fast Track status; and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule, for the treatment of chronic pain, fibromyalgia that has completed multiple Phase 1 trial programs and expected to initiate Phase 2 trials this year. For further information regarding the SP-102 Phase 3 efficacy trial, see NCT identifier NCT03372161 – <u>Corticosteroid Lumbar Epidural Analgesia for Radiculopathy – Full Text View – ClinicalTrials.gov</u>.

------

Scilex Holding Company is headquartered in Palo Alto, California, with operations in both Palo Alto and San Diego, California. For further information please visit <u>www.scilexholding.com</u>.

**About Sorrento Therapeutics, Inc.** 

Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19. Sorrento's multimodal, multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as Abivertinib, next-generation tyrosine kinase inhibitors ("TKIs"), fully human antibodies ("G-MAB<sup>™</sup> library"), immuno-cellular therapies ("DAR-T<sup>™</sup>"), antibody-drug conjugates ("ADCs"), and oncolytic virus ("Seprehvec<sup>™</sup>"). Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including STI-1558, COVI-MSC<sup>™</sup>; and diagnostic test solutions, including COVIMARK<sup>™</sup>.

Sorrento's commitment to life-enhancing therapies for patients is also demonstrated by our effort to advance a TRPV1 agonist, non-opioid pain management small molecule, resiniferatoxin ("RTX"), and SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA<sup>™</sup>), a novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, and to commercialize ZTlido<sup>®</sup> (lidocaine topical system) 1.8% for the treatment of postherpetic neuralgia (PHN). RTX has been cleared for a Phase II trial for intractable pain associated with cancer and a Phase II trial in osteoarthritis patients. Positive final results from the Phase III Pivotal Trial C.L.E.A.R. Program for SEMDEXA<sup>™</sup>, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022. ZTlido<sup>®</sup> was approved by the FDA on February 28, 2018.

For more information visit <u>www.sorrentotherapeutics.com</u>.

**Contacts:** 

For Scilex Holding Company

Jaisim Shah

Chief Executive Officer

Scilex Holding Company

960 San Antonio Road

Palo Alto, CA 94303

Office: (650) 516-4310

Email: <u>jshah@scilexpharma.com</u>

Website: <u>www.sorrentotherapeutics.com</u> and <u>www.scilexholding.com</u>

**Investors and Media Contact:** 

Elizabeth Czerepak

Email: <u>mediarelations@sorrentotherapeutics.com</u>

Website: www.sorrentotherapeutics.com

Sorrento<sup>®</sup> and the Sorrento logo are registered trademarks of Sorrento Therapeutics, Inc.

G-MAB<sup>™</sup>, DAR-T<sup>™</sup>, Seprehvec<sup>™</sup>, SOFUSA<sup>™</sup>, COVI-MSC<sup>™</sup>, COVIMARK<sup>™</sup>, Ovydso<sup>™</sup> and Fujovee<sup>TM</sup> are trademarks of Sorrento Therapeutics, Inc.

------

SEMDEXA<sup>™</sup> (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a wholly-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA is planned.

ZTlido<sup>®</sup> is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company.

Gloperba<sup>®</sup> is an exclusive, transferable license to use the trademark by Scilex Holding Company.

All other trademarks are the property of their respective owners.

<sup>©</sup> 2023 Sorrento Therapeutics, Inc. All Rights Reserved.